Low disease prevalence and inappropriate implantable cardioverter defibrillator shock rate in brugada syndrome: A nationwide study

Europace

Volumn 14, Issue 7, 2012, Pages 1025-1029

  Holst, Anders Gaarsdal ^a,b   Jensen, Henrik Kjærulf ^c   Eschen, Ole ^d   Henriksen, Finn Lund ^e   Kanters, Jørgen ^f   Bundgaard, Henning ^b   Svendsen, Jesper Hastrup ^a,b,g   Haunsø, Stig ^a,b,g   Tfelt Hansen, Jacob ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Brugada syndrome; Epidemiology; Implantable cardioverter defibrillator

Indexed keywords

ADULT; ARTICLE; BRUGADA SYNDROME; CARDIOGENIC SHOCK; DEFIBRILLATOR; DENMARK; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; TREATMENT DURATION;

ADULT; BRUGADA SYNDROME; DEFIBRILLATORS, IMPLANTABLE; DENMARK; ELECTRIC INJURIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84862984754     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus002     Document Type: Article

References (30)

1. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;111:659-70.
2. Probst V, Veltmann C, Eckardt L, Meregalli PG, Gaita F, Tan HL et al. Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada syndrome registry. Circulation 2010;121:635-43.
3. Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Longterm follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and st-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73-8.
4. Sarkozy A, Boussy T, Kourgiannides G, Chierchia G-B, Richter S, De Potter T et al. Long-term follow-up of primary prophylactic implantable cardioverterdefibrillator therapy in Brugada syndrome. Eur Heart J 2007;28:334-44.
5. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391-6.
6. Hu D, Barajas-Martinez H, Burashnikov E, Springer M, Wu Y, Varro A et al. A Mutation in the {beta}3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ Cardiovasc Genet 2009;2:270-8.
7. Antzelevitch C. Genetic basis of Brugada syndrome. Heart Rhythm 2007;4:756-7.
8. Burashnikov E, Pfeiffer R, Barajas-Martinez H, Delpón E, Hu D, Desai M et al. Mutations in the cardiac L-type calcium channel associated with inherited j wave syndromes and sudden cardiac death. Heart Rhythm 2010;7:1872-82.
9. Giudicessi JR, Ye D, Tester DJ, Crotti L, Mugione A, Nesterenko VV et al. Transient outward current (Ito) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. Heart Rhythm 2011;8:1024-32.
10. Wilde AAM, Ackerman MJ. Exercise extreme caution when calling rare genetic variants novel arrhythmia syndrome susceptibility mutations. Heart Rhythm 2010;7:1883-5.
11. Pecini R, Cedergreen P, Theilade S, Haunsø S, Theilade J, Jensen GB. The prevalence and relevance of the Brugada-type electrocardiogram in the Danish general population: data from the Copenhagen City Heart Study. Europace 2010;12: 982-6.
12. Tsuji H, Sato T, Morisaki K, Iwasaka T. Prognosis of subjects with Brugada-type electrocardiogram in a population of middle-aged Japanese diagnosed during a health examination. Am J Cardiol 2008;102:584-7.
13. Veltmann C, Schimpf R, Echternach C, Eckardt L, Kuschyk J, Streitner F et al. A prospective study on spontaneous fluctuations between diagnostic and nondiagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification. Eur Heart J 2006;27:2544-52.
14. Sinner MF, Pfeufer A, Perz S, Schulze-Bahr E, Monnig G, Eckardt L et al. Spontaneous Brugada electrocardiogram patterns are rare in the German general population: results from the KORA study. Europace 2009;11:1338-44.
15. Gallagher MM, Forleo GB, Behr ER, Magliano G, De Luca L, Morgia V et al. Prevalence and significance of Brugada-type ECG in 12,012 apparently healthy European subjects. Int J Cardiol 2008;130:44-8.
16. Hermida J-S, Lemoine J-L, Aoun FB, Jarry G, Rey J-L, Quiret J-C. Prevalence of the Brugada syndrome in an apparently healthy population. Am J Cardiol 2000;86: 91-4.
17. Letsas KP, Gavrielatos G, Efremidis M, Kounas SP, Filippatos GS, Sideris A et al. Prevalence of Brugada sign in a Greek tertiary hospital population. Europace 2007;9:1077-80.
18. Benito B, Brugada R, Brugada J, Brugada P. Brugada Syndrome. Prog Cardiovasc Dis 2008;51:1-22.
19. Yokokawa M, Noda T, Okamura H, Satomi K, Suyama K, Kurita T et al. Comparison of long-term follow-up of electrocardiographic features in Brugada syndrome between the SCN5A-positive probands and the SCN5A-negative probands. Am J Cardiol 2007;100:649-55.
20. Hong K, Brugada J, Oliva A, Berruezo-Sanchez A, Potenza D, Pollevick GD et al. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations. Circulation 2004;110:3023-7.
21. Smits JPP, Eckardt L, Probst V, Bezzina CR, Schott JJ, Remme CA et al. Genotypephenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 2002;40:350-6.
22. Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Gerard F et al. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation 2006;114:2317-24.
23. Rosso R, Glick A, Glikson M, Wagshal A, Swissa M, Rosenhek S et al. Outcome after implantation of cardioverter defribrillator in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU). Isr Med Assoc J 2008;10:435-9.
24. Giustetto C, Drago S, Demarchi PG, Dalmasso P, Bianchi F, Masi AS et al. Risk stratification of the patients with Brugada type electrocardiogram: a communitybased prospective study. Europace 2009;11:507-13.
25. Gehi AK, Duong TD, Metz LD, Gomes JA, Mehta D. Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis. J Cardiovasc Electrophysiol 2006;17:577-83.
26. Postema PG,Wolpert C, Amin AS, Probst V, Borggrefe M, Roden DM et al. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm 2009;6:1335-41.
27. Raju H, Papadakis M, Govindan M, Bastiaenen R, Chandra N, O'Sullivan A et al. Low prevalence of risk markers in cases of sudden death due to Brugada syndrome: relevance to risk stratification in Brugada syndrome. J Am Coll Cardiol 2011;57:2340-5.
28. Winkel BG, Holst AG, Theilade J, Kristensen IB, Thomsen JL, Ottesen GL et al. Nationwide study of sudden cardiac death in persons aged 1-35 years. Eur Heart J 2011;32:983-90.
29. van der Werf C, Hofman N, Tan HL, van Dessel PF, Alders M, van der Wal AC et al. Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in The Netherlands. Heart Rhythm 2010;7:1383-9.
30. Behr ER, Dalageorgou C, Christiansen M, Syrris P, Hughes S, Tome Esteban MT et al. Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families. Eur Heart J 2008;29:1670-80.